Waters Q1 revenue of $1.267 billion beats guidance; raises 2026 EPS outlook
Waters reported first-quarter 2026 revenue of $1.267 billion, $56 million above the high end of its guidance range, and adjusted EPS of $2.70, up 20% from $2.25 a year earlier. The company raised its full-year 2026 adjusted EPS guidance to $14.40 to $14.60 and its organic constant currency revenue growth guidance to 6.5% to 8.0%. GAAP results were a loss of $0.87 per diluted share, reflecting acquisition-related purchase accounting charges from the Becton, Dickinson biosciences and diagnostics business acquired February 9, 2026.
Key points
- Revenue was $1.267 billion versus $662 million a year earlier, including $520 million from the acquired Biosciences and Diagnostic Solutions businesses.
- Organic revenue grew 13% as reported and 11% in constant currency, to $747 million.
- GAAP diluted loss of $0.87 per share compared with diluted EPS of $2.03 a year earlier; purchased intangibles amortization was $152 million.
- Second-quarter 2026 adjusted EPS guidance is $2.95 to $3.05; full-year 2026 reported revenue is expected at $6.405 billion to $6.455 billion.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 05, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.